Regulation of the renal angiotensin II receptor gene in acute unilateral ureteral obstruction. We have shown that acute (24-hr) unilateral ureteral obstruction (UUO) induces the genes encoding for renin, in juxtaglomerular apparatuses and in tubules, for angiotensin converting enzyme in vascular endothelial cells, and for angiotensinogen in perivascular fat. These molecular changes occur in temporal association to marked reductions in renal blood flow (RBF) and glomerular filtration rate (GFR), suggesting that angiotensin II (Ang H) is at least partly responsible for the renal vasoconstriction. We tested the hypothesis that down-regulation of the Ang II type-i receptor (AT1-R) gene occurs in UUO in response to Ang II, by examining the effects of an ACE inhibitor [lisinopril (Li), 5 mg/kg/day] and of the specific nonpeptidic AT1-R blocker, losartan (Lo) (10 mg/kg/day). UUO or sham operated (which included manipulation but not obstruction of the ureter) rats (S) were studied. Northern blot analysis of the steady state concentration of AT1-R mRNA corrected for GAPDH mRNA showed a marked decrease in receptor expression (-77%, N = 4, P < 0.01) in the obstructed kidney (UUO) compared to S; sham diminished gene expression modestly compared to the contralateral kidneys (C) of UUO. In situ hybridization for AT1-R mRNA also showed diminished expression in UUO compared to C kidneys (N = 4). Treatment of UUO rats (N =4) with Lo increased AT1-R mRNA five times above the levels in UUO rats receiving vehicle; the increase induced by Li was 50% that of Lo; S (N = 4) and C (N = 4) did not change. Losartan, but not vehicle treatment increased RBF (sixfold) and GFR (fivefold) in the UUO kidneys. We conclude that UUO leads to down-regulation of AT1-R mRNA, and that this effect is mediated by Ang II, which is also responsible for a major component of the renal hemodynamic changes. Some function of UUO or ureteral manipulation, possibly stretch or nerve stimulation, differentially regulates the genes encoding for the renin-angiotensin system in the kidney.
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Acute (24 hr) unilateral ureteral obstruction (UUO) leads to a progressive increase in renal vascular resistance (RVR) and a marked decrease in renal blood flow (RB F) and glomerular filtration rate (GFR) [1, 2] . Studies performed in the last decade have demonstrated a role of several potent vasoactive substances in the renal hemodynamic changes of UUO, including angiotensin (Ang) II [3] , thromboxane A2 [4] , prostaglandins (PGE2, PGI2) [5, 6] , bradykinin [71, atrial natnuretic peptide [8] , and nitric oxide [9] . A large body of evidence, however,
We have recently reported that UUO leads to enhanced expression of RAS genes including those of renin (R), angiotensinogen (Ao) and angiotensin I-converting enzyme (ACE) in the obstructed kidney [11] . Furthermore, losartan, a non-peptidic Ang II type-i receptor (AT1-R) blocker, resulted in marked recovery of renal function after release of 24-hours UUO in awake rats [12] . These findings suggest that the RAS plays a fundamental role in UUO and that some component thereof (hemodynamic changes, stretch, pressure, obstruction to flow, etc.) induces transcriptional or post-transcriptional changes in RAS mRNAs. Evidence for increased production of Ang II in the obstructed kidney has been obtained in pigs with acute UUO and in rats with chronic UUO [10, 13] . Under conditions of increased local Ang II production, increased AT1-R mRNA expression would lead to increased synthesis of receptor molecules and would contribute to increased sensitivity and responsiveness to the vasoconstrictor actions of this peptide, and worsen the decreased renal blood flow in UUO. Nevertheless, the effect of acute UUO on the renal expression of the AT1-R gene is unknown. The present study was designed to examine the effect of UUO on AT1-R mRNA and to determine the role of Ang II in the changes, if any, of the AT1-R gene expression.
In addition, we have examined the role Ang II on the renal hemodynamics changes of UUO by testing the effect of losartan.
Methods

Male Wistar rats weighing 150 to 200 g (Charles River
Laboratories, Wilmington, Massachusetts, USA) were used for these experiments. The rats were housed individually in a room providing 12-hour light and dark cycles and were maintained on standard Purina rat pellets with free access to food and water at all times prior to the experiment. General anesthesia was induced by intraperstoneal injection of ketamine (100 mg/kg body wt) and xylazine(lO mg/kg body wt), and the left ureter was exposed through a small left flank incision and dissected from its retroperitoneal site. Complete occlusion of the ureter was performed by a 4-0 silk square knot (N = 12). The abdominal incision was closed and animals were allowed to recover prior to returning to their cages. Eight rats were sham operated: ureter exposed and manipulated (naked-eye) as in the experimental groups but not tied (N = 4); in one rat both sides were dissected (naked eye) while in another the procedure was done under the dissecting microscope and the utmost care taken to not injure the ureter in any way. This was also done bilaterally in another rat that had as its comparison a rat that underwent bilateral free-hand dissection (naked eye). Two others were ipsilateral controls (C) (rats operated, but ureters not manipulated). Four additional groups of four rats each were studied as follows: group A was sham operated; group B was also sham operated and received treatment with losartan, given by gavage (10 mg/kg/day) for five days prior to and including the day of surgery; group C received the converting enzyme inhibitor (CEI) lisinopril (5 mg/kg/day) by gavage for five days including the day of UUO; and group D received losartan as already described for group B before UUO. Four additional UUO rats were treated with losartan as described above and GFR, measured by inulin clearance, and effective renal plasma flow measured by PAH clearance as already described from this laboratory [11] . Another group of rats (N = 4) received an equivalent amount of vehicle by gavage for the same period of time. Losartan was a gift of Dr. Ronald D. Smith, E.I. DuPont Merck Pharmaceutical (Wilmington, Delaware, USA) and lisinopril was a gift of Merck Sharpe and Dohme (West Point, Pennsylvania, USA).
At the end of the experiments (24 hrs) the rats were sacrificed with an anesthetic overdose; the kidneys were immediately removed from all rats except those used for the renal hemodynamic studies and snap-frozen in liquid nitrogen. Frozen kidneys were chiseled into small pieces, which were placed in guanidium isothiocyanate (GTC), and homogenized immediately. Samples were then stored at 4°C until analysis.
RNA extraction and Northern hybridization analysis
Total RNA was extracted by the guanidine thiocyanate method, as previously described [14] . A total of 20 jig RNA was run on 1% agarose gels using formaldehyde. RNA was transferred by capillary blotting using standard procedures and Immobilon-N membranes (charge-modified PVDF transfer membranes, Millipore Corp., Bedford, Massachusetts, USA). Blots were washed in 6x SSC for 5 to 10 minutes, then baked under vacuum for one hour at 80°C. Preparation of riboprobes AT1 receptor cDNA was originally cloned in the pCDM8 expression vector by Murphy et al [15] . The AT1 receptor cDNA, a gift of Drs. T.J. Murphy and R. W. Alexander, was subcloned into pGM4 vector, transcribed and labeled using 32P-UTP (Amershan, Arlington Heights, Illinois, USA), specific activity 1200 Ci/mmol. A full-length antisense transcript was used for hybridization.
Labeled riboprobes were prepared using 0.5 to I jig linear- and hybridization for GAPDH mRNA were performed as described above.
Densitometry analysis and mRNA quantflcation The autoradiographs were scanned using the Image Quant'°c omputing densitometer (Molecular Dynamics, Sunnyvale, California, USA). Results are expressed as relative density. We used the classical approach of housekeeping gene analysis and ethidium bromide stain to ascertain equal loading and specificity of response. We have previously shown that UUO does not alter GAPDH mRNA expresssion [11] . Relative densitometry was determined by the signal density of each RNA sample hybridized to the AT1-R riboprobe divided by that hybridized to the GAPDH probe.
In situ hybridization The AT1 receptor probe was a full-length antisense cRNA labeled with 35S-UTP (Amersham), specific activity 1200 Cit mmol. The experiments were controlled by hybridizing serial sections with the same cRNA probe transcribed in the sense orientation. In situ hybridization was performed as previously described [16, 17] . Briefly, cryosections were prepared with paraformaldehyde, proteinase K (Sigma Chemical, St. Louis, Missouri, USA), and prehybridized in 100 ml hybridization buffer (50% formamide, 0.3 M NaCL, 20 mrs Tris pH 8.0, 5 mM EDTA, 0.02% polyvinylpyrrolidine, 0.02% Ficoll, 0.02% bovine serum albumin, 10% dextran sulfate, and 10 mrt dithiothreitol) at 42°C. The hybridizations were performed using 600,000 cpm of 35S-riboprobe at 55°C. After hybridization, the sections were washed with 2x SSC (lx SSC = 150 mrt NaCI, 15 m Na citrate, pH 7.0) with 10 mrss /3-mercaptoethanol and 1 mrt EDTA, treated with RNase (Sigma), again washed in the same buffer, followed by a high stringency wash in 0.1 x SSC with 10 mrs /3-mercaptoethanol and 1 m EDTA, at 52°C. The slides were then washed in 0.5 x SSC and dehydrated in graded alcohols containing 0.3 M NH4Ac, dipped in Kodak NTB2 nuclear emulsion, dried in the dark at 4°C with desiccant for two to eight weeks, and developed at 15°C. Slides were counterstained with hematoxylin and eosin.
Analytical procedures Plasma renin activity (PRA) was measured by determinig the amount of angiotensin I generated during one hour of incubation at 37°C in the presence of ACE inhibitors and angiotensinases by radioimmunoassay as previously reported [18] .
Statistical methods
Values are expressed as mean SEM. One way analysis of variance (ANOVA) was used for comparisons between groups. GAPDH mRNA to which an arbitrary value of one was assigned. AT1-R in the obstructed kidney was down-regulated by -75% (P < 0.01).
When each animal was used as its own control (left vs. right kidney) significance was obtained by paired t-test. A value of P < 0.05 was accepted as significant. Table 1 shows the results of losartan treatment on effective renal plasma flow (RPF) and GFR in each kidney of the rats studied (N = 4). ERPF and GFR improved -fivefold from their lowest values. GFR in the obstructed kidney rose from a value of 8% to 37% of the control kidney GFR. ERPF in the obstructed kidney rose from 12% to a value of 66% of the control kidney ERPF. Values of GFR and ERPF before and after losartan were significantly different; both values remained significantly different from control even after losartan treatment. These results confirm our previous studies using losartan in UUO [12] . We have also already reported similar results with lisinopril [19] . Blood pressure fell to similar levels in rats treated with losartan or lisinopril (80 vs. 88 mm Hg; P =NS), indicating that the doses of these drugs were comparable in both groups.
Changes in PRA (Table 2) were not significant when shams were compared to control rats. UUO increased PRA as compared to control animals (P = 0.04); as expected, interruption of the feedback between Ang II and renin secretion by losartan and lisinopril markedly increased PRA in sham (not shown for Li) and UUO rats. In sham rats, losartan increased PRA eight times over the sham; moreover, PRA was 45 times greater in losartan-treated UUO rats than the average PRA value of all sham and control rats. PRA parallels the renin secretory rate, which is partly dependent of RPF; therefore, since ERPF rose only fivefold, the marked increase in PRA in losartan treated UUO rats indicates a major intrarenal effect of the inhibitor to reverse the renin secretion suppressing action of Ang II.
Northern analysis and mRNA quantification Compared to the contralateral kidney and control ipsilateral kidneys (as described above), the receptor mRNA signal was markedly decreased in the obstructed kidney (Figs. 1 and 2 ). Densitometry analysis (Fig. 3) revealed the signal to be significantly lower (-77%) in UUO than in controls. There was no statistical difference in receptor mRNA expression between the contralateral and ipsilateral control kidneys (Table 3) . Sham operation, done by free-hand (naked eye) dissection of the left ureter from its retroperitroneal bed, consistently led to a decrease in the expression of the AT,-R inRNA in the ipsilateral kidney compared to the contralateral kidney and to control ipsilateral kidneys (operated rats whose left ureter was untouched; Table 3 ). AT1-R mRNA expression was decreased by -40% in the sham kidney compared to the contralateral or ipsilateral controls. The difference between sham and contralateral and ipsilateral controls was significant and accounted for 25 to 30% of the reduction in steady state AT1-R mRNA concentration, When free-hand unilateral and bilateral dissection was compared to dissecting microscope-prepared shams (Figs. 1 and 2) free-hand dissection led to reduced expression of the message while, when careful! ureteral dissection was performed the signal from that kidney could not be distinguished from untouched kidneys.
The most striking finding in our experiments is the fact that both lisinopril and losartan caused a marked increase in the expression of AT1-R mRNA in the kidney with complete ureteral obstruction as well as in the kidneys whose ureters were manipulated (Table 3) . By contrast, losartan did not change the receptor expression in control and contralateral kidneys. The effects of lisinopril were only examined in UUO, but the converting enzyme inhibitor consistently led to no change in the contralateral kidney as compared to controls. Conversely, it doubled-to normal levels-the AT,-R mRNA concentration in the obstructed kidney. The effect of losartan was more dramatic than that of lisinopril. In all instances, losartan Increased steady state AT1-R mRNA concentrations from two to five times the values in the untreated sham and the untreated UUO rats. Moreover, losartan raised receptor mRNA values two to three times higher than lisinopril.
In situ hybridization studies In situ hybridization showed localization of AT1-R mRNA signals in glomeruli and tubules that were more prominent in contralateral compared to obstructed kidneys. An obstructed kidney exhibiting sparse signals in both tubules and glomeruli is shown in Figure 4 . Tissue sections from control and sham kidneys did not differ from each other nor from those of the contralateral kidneys of rats with UUO (data not shown). While it is not possible to precisely quantitate the degree of hybridization signal, these data are in general agreement with the clear-cut down-regulation of AT,-R mRNA in obstructed kidneys without change in expression of the receptor gene in the contralateral kidney observed by Northern analysis. Sense AT,-R cRNA did not lead to hybridization signals in any of the tissues tested (data not shown).
Discussion
The present study shows that 24-hour UUO is associated with down-regulation of AT1-R gene expression when the ureter is obstructed or manipulated without careful care not to traumatize the area dissected. Careful dissection (under a microscope) of the ureter did not down-regulate the message, which was also unaltered in control or contralateral kidneys. Suppression of AT,-R mRNA expression in kidneys with either manipulated (grossly dissected) or obstructed kidneys suggests that mechanical, humoral, or perhaps neural stimuli arising from the ureter may operate in the regulation of kidney AT1-R mRNA. The fact, however, that obstruction resulted in a greater inhibition of steady state mRNA than ureteral manipulation alone, and that the difference in this measurement between kidneys with manipulated and obstructed ureters was significant, is indirect evidence that these two stimuli are capable, possibly by different mechanisms, of suppressing gene transcription. While mechanical changes such as alterations in urine flow patterns, increased pressure and/or stretch of the ureter or of the intrarenal tubule system, may play a role in the regulation of AT1-R 
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A mRNA expression, the results obtained in animals treated with losartan or lisinopril suggest that, whatever the initiating step might be, a hormonal pathway or mechanism is involved.
Moreover, it is clear from our results with losartan and the CEI lisinopril that Ang II is a critical hormone in the renal regulation of AT1-R mRNA during obstruction and/or manipulation of the ureter. It is of interest that Paxton et al [20] found marked AT1-R immunoreactivity in the smooth muscle cells of the ureter and renal pelvis of both Wistar and Sprague-Dawley rats, suggesting a role for Ang II in the contractility of these structures. It is conceivable that the presence of these Ang II responsive cells may be related to the changes in receptor gene expression in the kidney after manipulation or obstruction of the ureter, the nature of which remains to be uncovered. Kopp and her associates [21, 22] have shown that acute UUO, albeit of short duration (30 to 40 mm), increases ipsilateral afferent renal nerve activity and decreases contralateral efferent renal nerve activity. The sensory receptors activated by these interventions have been localized to the renal pelvis [211. Furthermore, inhibitory reno-renal reflexes in response to mechanical and chemical activation of these receptors are prostaglandinmediated [22] . It is well known that a close interrelationship exists among prostaglandins, renin secretion and thus the response to Ang II in UUO [23, 24] . The full significance, however, of the renal nerves and of mechanical alterations in ureteral and pelvic functions in the regulation of the renal expression of AT1-R mRNA remains to be clarified. Nevertheless, in view of the fact that ureteral manipulation reduced ipsilateral renal AT1-R gene expression, we suggest the possibility that afferent renal nerve activity serves a role in the regulation of this and perhaps other genes in the RAS cascade.
Inasmuch as 24-hour UUO may be compared to 30 minute UUO, and in view of the lack of change in AT1-R mRNA, diminished efferent renal nerve activity in the contralateral kidney does not seem to affect regulation of this gene.
A recent study by El-Dahr and collaborators [10] has shown that chronic UUO increases ipsilateral renin mRNA, but leads to down-regulation of kallikrein gene expression, increased plasma ACE-kininase II and reduced immunoreactive kallikrein content in the ipsilateral kidney. In addition, we have shown an increase in both renin and ACE mRNAs expression in acute UUO [11] . These results suggest a role for bradykinin in the intrarenal regulation of RAS genes. Lisinopril, which by inhibition of ACE-kininase II should increase local bradykinin production, was less effective in restoring AT1-R mRNA than losartan, which does not alter bradykinin production [25] . This may be indicative of an AT1-R gene suppressive effect of bradykinin and further suggests the possibility of at least a permissive role of the kallikrein system in the intrarenal regulation of the RAS.
Reduced steady state levels of AT1-R mRNA in acute UUO would lead to decreased transcription rate, diminished synthesis of receptor molecules, and diminished response to locally generated Ang II. Our findings of a reduced renal receptor mRNA concentration are in keeping with the elevated plasma renin activity (and presumably Ang II levels) in the early phases of UUO since Ang II would lead to down-regulation of its receptor in the kidney [26, 27] . Receptor down-regulation would be potentiated by the increased intrarenal Ang II production which has been shown to occur in response to UUO [10, 13] . The restoration and enhancement of receptor gene expression, the partial but significant hemodynamic recovery and the dramatic increase in PRA induced by both losartan and lisinopril treatment in UUO, are in keeping with the proposal of the principal role of Ang II in down-regulation of receptor gene expression and receptor synthesis.
In a previous study, we found that UUO leads to an early rise in plasma renin activity and to marked elevations in the steady state concentration of renin mRNA as determined by Northern analysis [11] . In addition, it was shown that vascular endotheliusn and perivascular fat exhibited increased expression of ACE and angiotensinogen mRNA, respectively. Thus the crucial first 24 hours of obstruction are accompanied by increased expression of the mRNAs for renin, angiotensinogen, angiotensin converting enzyme and, possibly, increased angiotensm II production which eventually down-regulates the receptor mRNA. These findings indicate that the intrarenal RAS is regulated by some component of the obstructive process and, in view of the response to losartan, that Ang II contributes in a major way to the hemodynamic alterations observed.
In summary, we conclude that acute (24 hr) UUO leads to increased intrarenal production of Ang II which is responsible for the hemodynamic changes and down-regulation of the AT1-R mRNA in the obstructed kidney. The increased Ang II synthesis results from enhanced expression of renin, angiotensinogen and angiotensin I-converting enzyme mRNAs in UUO [11] . Some function of UUO, possibly stretch or pressure, differentially regulates the genes encoding for the renin-angiotensin system.
